Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Factor

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1995
Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's diseaseS A Factor, E S Molho, D L Brown
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Delayed-onset dystonia associated with corticospinal tract dysfunctionS A Factor, J Sanchez-Ramos, W J Weiner
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Trauma as an etiology of parkinsonism: a historical review of the conceptS A Factor, J Sanchez-Ramos, W J Weiner
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Clinical comparison of tardive and idiopathic cervical dystoniaE S Molho, P J Feustel, S A Factor
Movement Disorders : Official Journal of the Movement Disorder Society|January 14, 2000
Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's diseaseS A Factor, D L Brown, E S Molho
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1995
Psychogenic movement disorders: frequency, clinical profile, and characteristicsS A Factor, G D Podskalny, E S Molho
Journal of the Neurological Sciences|December 1, 1994
Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case reportS A Factor, G D Podskalny, K D Barron
European Journal of Neurology|August 1, 2017
The role of neurotransmitters in the development of Parkinson's disease-related psychosisS A Factor, W M McDonald, F C Goldstein
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1988
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapyS A Factor, J R Sanchez-Ramos, W J Weiner
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's diseaseW J Weiner, S A Factor, J R Sanchez-Ramos
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1995
Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's diseaseS A Factor, E S Molho, D L Brown
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Delayed-onset dystonia associated with corticospinal tract dysfunctionS A Factor, J Sanchez-Ramos, W J Weiner
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1988
Trauma as an etiology of parkinsonism: a historical review of the conceptS A Factor, J Sanchez-Ramos, W J Weiner
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Clinical comparison of tardive and idiopathic cervical dystoniaE S Molho, P J Feustel, S A Factor
Movement Disorders : Official Journal of the Movement Disorder Society|January 14, 2000
Subcutaneous apomorphine injections as a treatment for intractable pain in Parkinson's diseaseS A Factor, D L Brown, E S Molho
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1995
Psychogenic movement disorders: frequency, clinical profile, and characteristicsS A Factor, G D Podskalny, E S Molho
Journal of the Neurological Sciences|December 1, 1994
Persistent neuroleptic-induced rigidity and dystonia in AIDS dementia complex: a clinico-pathological case reportS A Factor, G D Podskalny, K D Barron
European Journal of Neurology|August 1, 2017
The role of neurotransmitters in the development of Parkinson's disease-related psychosisS A Factor, W M McDonald, F C Goldstein
Journal of Neurology, Neurosurgery, and Psychiatry|April 1, 1988
Parkinson's disease: an open label trial of pergolide in patients failing bromocriptine therapyS A Factor, J R Sanchez-Ramos, W J Weiner
Journal of Neurology, Neurosurgery, and Psychiatry|June 1, 1989
The efficacy of (+)-4-propyl-9-hydroxynaphthoxazine as adjunctive therapy in Parkinson's diseaseW J Weiner, S A Factor, J R Sanchez-Ramos
Pageof 8